Abbott Laboratories (ABT) Inventory (2009 - 2026)

Abbott Laboratories has disclosed Inventory across 18 years of filings, most recently posting $7.0 billion for Q1 2026.

• Inventory for Q1 2026 came in at $7.0 billion, up 5.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 billion (up 5.27% YoY), and the FY2025 annual result was $6.5 billion, up 4.75% from the prior year.
• Inventory came in at $7.0 billion for Q1 2026 at Abbott Laboratories, up from $6.5 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $7.0 billion in Q1 2026 to a low of $5.7 billion in Q1 2022.
• The 5-year median for Inventory is $6.6 billion (2023), against an average of $6.5 billion.
• Across the five-year window, Inventory gained 19.7% in 2022 and retreated 5.72% in 2024, its largest moves.
• Abbott Laboratories' Inventory stood at $6.2 billion in 2022, then advanced by 6.43% to $6.6 billion in 2023, then declined by 5.72% to $6.2 billion in 2024, then gained by 4.75% to $6.5 billion in 2025, then increased by 7.72% to $7.0 billion in 2026.
• The last three Inventory figures came in at $7.0 billion (Q1 2026), $6.5 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.